Revealed core proteomics instrument during US HUPO 2026 following successful field evaluation at the Buck Institute for ...

Guidance language shifted to a more specific projection of 15%-20% operating expense growth for 2026, compared to less specific spending outlook in Q3. Management's confidence increased, underpinned ...

Nautilus Biotechnology (NASDAQ:NAUT) used its fourth-quarter 2025 earnings call to highlight recent steps toward commercialization of its proteomics platform, alongside continued cost reductions and ...

Star Trek: Voyager gave fans plenty of WTF episodes to look back on, but also some that helped make The Doctor one of the ...

Annual R&D Expenses -- $41.1 million in 2025, a 19% decrease driven primarily by a $4.5 million reduction in lab and ...

Since Starfleet Academy first began, haters have lobbed one accusation at it above all others: “it doesn’t feel like Star Trek.” Recently, though, Starfleet Academy has been addressing this problem ...

LambdaVision, a company that has used microgravity experiments on the ISS to develop an artificial retina, has booked space on a planned commercial station.

SEATTLE, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the ...

Plus, that 'Voyager' reference explained.

Commentary: A report shows more than 10,000 workers with doctorates in science, technology, engineering and mathematics, or ...